Goldman Sachs’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $19M | Sell |
575,141
-72,396
| -11% | -$3.07M | ﹤0.01% | 2479 |
|
|
2025
Q4 | $30M | Sell |
647,537
-154,697
| -19% | -$6.47M | ﹤0.01% | 1979 |
|
|
2025
Q3 | $28.1M | Buy |
802,234
+565,444
| +239% | +$19.7M | ﹤0.01% | 1923 |
|
|
2025
Q2 | $7M | Buy |
236,790
+61,470
| +35% | +$1.75M | ﹤0.01% | 3101 |
|
|
2025
Q1 | $5.23M | Sell |
175,320
-44,391
| -20% | -$1.36M | ﹤0.01% | 3303 |
|
|
2024
Q4 | $6.29M | Sell |
219,711
-355,528
| -62% | -$11.8M | ﹤0.01% | 3216 |
|
|
2024
Q3 | $22.2M | Buy |
575,239
+229,715
| +66% | +$8.19M | ﹤0.01% | 1973 |
|
|
2024
Q2 | $11.1M | Buy |
345,524
+181,574
| +111% | +$6.3M | ﹤0.01% | 2403 |
|
|
2024
Q1 | $6.36M | Sell |
163,950
-41,112
| -20% | -$1.44M | ﹤0.01% | 2875 |
|
|
2023
Q4 | $6.31M | Sell |
205,062
-3,940
| -2% | -$98.7K | ﹤0.01% | 2966 |
|
|
2023
Q3 | $4.67M | Sell |
209,002
-3,815
| -2% | -$87K | ﹤0.01% | 3044 |
|
|
2023
Q2 | $4.57M | Buy |
212,817
+95,786
| +82% | +$2.17M | ﹤0.01% | 3178 |
|
|
2023
Q1 | $2.81M | Buy |
117,031
+28,843
| +33% | +$765K | ﹤0.01% | 3575 |
|
|
2022
Q4 | $2.05M | Sell |
88,188
-14,921
| -14% | -$301K | ﹤0.01% | 3928 |
|
|
2022
Q3 | $1.65M | Buy |
103,109
+41,988
| +69% | +$740K | ﹤0.01% | 4129 |
|
|
2022
Q2 | $1.08M | Sell |
61,121
-39,682
| -39% | -$668K | ﹤0.01% | 4549 |
|
|
2022
Q1 | $2.05M | Sell |
100,803
-47,317
| -32% | -$894K | ﹤0.01% | 4237 |
|
|
2021
Q4 | $2.77M | Sell |
148,120
-36,850
| -20% | -$718K | ﹤0.01% | 3966 |
|
|
2021
Q3 | $3.65M | Buy |
184,970
+7,585
| +4% | +$164K | ﹤0.01% | 3620 |
|
|
2021
Q2 | $4.19M | Sell |
177,385
-12,612
| -7% | -$291K | ﹤0.01% | 3494 |
|
|
2021
Q1 | $4.5M | Buy |
189,997
+123,678
| +186% | +$2.94M | ﹤0.01% | 3225 |
|
|
2020
Q4 | $1.33M | Buy |
66,319
+21,193
| +47% | +$414K | ﹤0.01% | 4016 |
|
|
2020
Q3 | $939K | Sell |
45,126
-33,005
| -42% | -$596K | ﹤0.01% | 4125 |
|
|
2020
Q2 | $1.37M | Sell |
78,131
-29,367
| -27% | -$575K | ﹤0.01% | 3743 |
|
|
2020
Q1 | $1.75M | Sell |
107,498
-138,655
| -56% | -$2.86M | ﹤0.01% | 3390 |
|
|
2019
Q4 | $5.07M | Buy |
246,153
+165,173
| +204% | +$2.75M | ﹤0.01% | 2951 |
|
|
2019
Q3 | $930K | Sell |
80,980
-13,291
| -14% | -$152K | ﹤0.01% | 4077 |
|
|
2019
Q2 | $1.24M | Sell |
94,271
-83,902
| -47% | -$1.12M | ﹤0.01% | 3852 |
|
|
2019
Q1 | $2.7M | Sell |
178,173
-33,984
| -16% | -$544K | ﹤0.01% | 3418 |
|
|
2018
Q4 | $3.64M | Sell |
212,157
-119,628
| -36% | -$2.05M | ﹤0.01% | 3141 |
|
|
2018
Q3 | $4.89M | Buy |
331,785
+222,408
| +203% | +$3.94M | ﹤0.01% | 3007 |
|
|
2018
Q2 | $2.61M | Buy |
109,377
+54,024
| +98% | +$1.33M | ﹤0.01% | 3452 |
|
|
2018
Q1 | $1.41M | Sell |
55,353
-56,671
| -51% | -$1.35M | ﹤0.01% | 3819 |
|
|
2017
Q4 | $2.07M | Buy |
112,024
+31,807
| +40% | +$456K | ﹤0.01% | 3778 |
|
|
2017
Q3 | $841K | Buy |
80,217
+31,907
| +66% | +$352K | ﹤0.01% | 4723 |
|
|
2017
Q2 | $604K | Sell |
48,310
-17,067
| -26% | -$169K | ﹤0.01% | 4933 |
|
|
2017
Q1 | $658K | Buy |
65,377
+29,731
| +83% | +$442K | ﹤0.01% | 4764 |
|
|
2016
Q4 | $555K | Buy |
35,646
+24,100
| +209% | +$401K | ﹤0.01% | 4969 |
|
|
2016
Q3 | $222K | Sell |
11,546
-32,542
| -74% | -$387K | ﹤0.01% | 5739 |
|
|
2016
Q2 | $522K | Sell |
44,088
-16,206
| -27% | -$268K | ﹤0.01% | 4820 |
|
|
2016
Q1 | $1.09M | Buy |
60,294
+19,460
| +48% | +$354K | ﹤0.01% | 4005 |
|
|
2015
Q4 | $1.12M | Buy |
+40,834
| New | +$860K | ﹤0.01% | 4185 |
|
|
2015
Q3 | – | Sell |
-40,430
| Closed | -$721K | – | 7294 |
|
|
2015
Q2 | $721K | Buy |
+40,430
| New | +$699K | ﹤0.01% | 4852 |
|
Other funds holding COLL
EAM
VCM
